Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/23/26 | Corxel Pharmaceuticals | VCT 220 for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Eledon Pharmaceuticals (ELDN) | tegoprubart for Kidney Transplant Rejection | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Pfizer (PFE) | sigvotatug vedotin for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Sumitovant Biopharma | Myfembree for Uterine Fibroids | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Haisco (002653) | HSK39297 for Paroxysmal Nocturnal Hemoglobinuria (PNH) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/17/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |